Results 61 to 70 of about 13,200 (163)

Effect of montelukast in preventing dengue with warning signs among patients with dengue: A multicenter, randomized, double-blind, placebo-controlled trial.

PLoS Neglected Tropical Diseases
BackgroundMontelukast has shown potential as a candidate treatment for dengue. This study aimed to evaluate the efficacy and safety of montelukast in preventing dengue with warning signs.MethodsThis multicenter, randomized, double-blind, placebo ...
Nattapat Nitinai, Worapong Nasomsong, Worayon Chuerboonchai, Akarawin Tweekittikul, Vutthikorn Khingmontri, Bawornnan Panuvatvanich, Thananut Bangchuad, Maynanchaya Pongpraijaroen, Tanapol Roongfa-Ngarm, Vasin Vasikasin   +9 more
doaj   +1 more source

Montelukast in mild persistent asthma in children [PDF]

, 2001
The efficacy of montelukast, a leukotriene receptor antagonist, in treatment of mild asthma was evaluated. METHODS: Thirty children aged 6 to14 years with mild persistent asthma (asthma history more than 12 months and > or = 15% FEV, improvement after ...
Cichocka-Jarosz, Ewa, Lis, Grzegorz, Białoruska, Beata, Głodzik, Izabela, Szczerbiński, Tomasz   +4 more
core  

Psychiatric Adverse Effects of Montelukast—A Nationwide Cohort Study

, 2023
BackgroundRecent observational studies suggest that the leukotriene receptor antagonist montelukast may have neuropsychiatric adverse effects; however, results are conflicting.ObjectiveTo assess whether montelukast exposure in adults with asthma is ...
Klaus Bønnelykke, Jordan, Alexander, Louise Lindhardt Toennesen, Sivapalan, Pradeesh, Howraman Meteran, Ulrik, Charlotte Suppli, Toennesen, Louise Lindhardt, Josefin Eklöf, Stæhr Jensen, Jens Ulrik, Eklöf, Josefin, Bønnelykke, Klaus, Alexander Jordan, Pradeesh Sivapalan, Charlotte Suppli Ulrik, Jens-Ulrik Stæhr Jensen, Meteran, Howraman   +15 more
core   +1 more source

Montelukast in Asthma Treatment in Croatia [PDF]

, 2005
The aim of this study was to determine the efficacy and safety of montelukast added to previous medication in the treatment of a mild and moderate asthma.
Samaržija, Miroslav, Kukulj, Suzana, Popović-Grle, Sanja, Pavičić, Fadila, Jakopović, Marko   +4 more
core  

Image2_Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network.TIFF

, 2021
Montelukast is a selective leukotriene receptor antagonist that is widely used to treat bronchial asthma and nasal allergy. To clarify the association between montelukast and neuropsychiatric adverse events (AEs), we evaluated case reports recorded ...
Eiichi Hinoi (301857), Noriaki Takeyama (11855618), Masatoshi Inden (619761), Natsumi Ueda (3207462), Yuri Nishibata (4710309), Mizuki Tanaka (4636117), Mitsuhiro Nakamura (308371), Ryogo Umetsu (4710310), Hiroyuki Tanaka (9428), Kiyoka Matsumoto (7474502), Kazuhiro Iguchi (5327258), Yoko Nakayama (11855615), Yamato Kato (4710306), Naoki Inagaki (9429), Shiori Hasegawa (2802643), Yoshinori Muto (11855639)   +15 more
core   +1 more source

Evaluation of analgesic, anti-inflammatory, and antipyretic activity of leukotriene receptor antagonist-montelukast: An experimental study

National Journal of Physiology, Pharmacy and Pharmacology, 2017
Background: Various inflammatory mediators are involved in initiating and sustaining pain/inflammation cascade. Recently, leukotrienes (LTs) have been shown to be important mediators in pain and inflammation.
Atul Mallikarjun Kolhe, Anand Kale
doaj   +1 more source

Possible montelukast-induced angioedema

, 2016
Purpose. A possible case of montelukast-induced angioedema is reported. Summary. A 46-year-old woman with a history of severe allergies, including food allergies, and angioedema was evaluated at the emergency department (ED) for an acute episode of ...
Sheikh-Taha, Marwan, Sabbagh, Racha
core   +1 more source

Effectiveness, safety, and cost-effectiveness of fixed-dose combination of montelukast–bilastine versus montelukast–levocetirizine in allergic rhinitis: A prospective, randomized, open-label, parallel-group study

Perspectives in Clinical Research
Introduction: Several fixed-dose combinations (FDCs) have been available for the treatment of allergic rhinitis (AR), of which montelukast and levocetirizine is one of the highly prescribed FDC.
Ganesh Natthuji Dakhale, Chaitali A. Chindhalore, Mohit Kumar, Vijay Bidkar   +3 more
doaj   +1 more source

pH‐Sensitive Alginate/Polyvinyl Alcohol/Chitosan Crosslinked With Tetraethyl Orthosilicate Polymeric Hybrid Hydrogel for Biomedical Application

SPE Polymers, Volume 7, Issue 4, October 2026.
Fabrication steps of Alginate, PVA and chitosan hydrogel crosslinked with TEOS for azithromycin drug delivery application. ABSTRACT The main aim of this study was to develop a cost‐effective, pH‐sensitive Alginate (Alg), PVA, and chitosan (Cs) (Alg/PVA/Cs) hydrogel biocompatible polymer for controlled drug release of azithromycin.
Safia Hassan, Mahrukh, Danial Mazhar, Alishbah Iftikhar Ahmed   +3 more
wiley   +1 more source

Role of montelukast in asthma treatment in 2025

This review paper explores the role and significance of antileukotriene therapy in asthma management. It highlights the involvement of the arachidonic acid metabolite-dependent pathway, regardless of the formal phenotype and, in some cases, the endotype ...
Rafał Pawliczak
core   +1 more source